1 Study Coverage 1.1 Human Immunoglobulin(pH4) for Intravenous Injection Product Introduction 1.2 Market by Type 1.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Type 1.2.2 1g/20ml 1.2.3 1.25g/25ml 1.2.4 2.5g/50ml 1.2.5 5g/100ml 1.2.6 10g/200ml 1.3 Market by Application 1.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size, Estimates and Forecasts 2.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue 2016-2027 2.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales 2016-2027 2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Human Immunoglobulin(pH4) for Intravenous Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Region (2022-2027) 3 Global Human Immunoglobulin(pH4) for Intravenous Injection Competitor Landscape by Players 3.1 Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Sales 3.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Revenue 3.2.1 Key Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Human Immunoglobulin(pH4) for Intravenous Injection Revenue in 2020 3.2.6 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Manufacturers 3.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Manufacturing Base Distribution, Product Types 3.4.1 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection Product Type 3.4.3 Date of International Manufacturers Enter into Human Immunoglobulin(pH4) for Intravenous Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Type (2016-2021) 4.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021) 4.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2016-2021) 4.1.3 Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Type (2022-2027) 4.2.3 Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Application (2016-2021) 5.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021) 5.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2016-2021) 5.1.3 Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021) 5.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 6.1.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales YoY Growth 2016-2027 6.1.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue YoY Growth 2016-2027 6.1.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Share in Global Market 2016-2027 6.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Players (International and Local Players) 6.2.1 Japan Top Human Immunoglobulin(pH4) for Intravenous Injection Players by Sales (2016-2021) 6.2.2 Japan Top Human Immunoglobulin(pH4) for Intravenous Injection Players by Revenue (2016-2021) 6.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Historic Market Review by Type (2016-2021) 6.3.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2021) 6.3.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Type (2016-2021) 6.3.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2021) 6.4 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) 6.4.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Type (2022-2027) 6.4.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Type (2022-2027) 6.5 Japan Human Immunoglobulin(pH4) for Intravenous Injection Historic Market Review by Application (2016-2021) 6.5.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2021) 6.5.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Application (2016-2021) 6.5.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021) 6.6 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) 6.6.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) 6.6.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 7.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 7.2.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 7.2.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 9.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 9.2.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 9.2.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 10.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 10.2.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 10.2.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Boya-Bio 12.1.1 Boya-Bio Corporation Information 12.1.2 Boya-Bio Description and Business Overview 12.1.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.1.5 Boya-Bio Recent Development 12.2 Beijing Tiantan Biological Products 12.2.1 Beijing Tiantan Biological Products Corporation Information 12.2.2 Beijing Tiantan Biological Products Description and Business Overview 12.2.3 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.2.5 Beijing Tiantan Biological Products Recent Development 12.3 Hualan Bio 12.3.1 Hualan Bio Corporation Information 12.3.2 Hualan Bio Description and Business Overview 12.3.3 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.3.5 Hualan Bio Recent Development 12.4 Guangdong Shuagnlin Bio-pharmacy 12.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information 12.4.2 Guangdong Shuagnlin Bio-pharmacy Description and Business Overview 12.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development 12.5 Weiguang Biological 12.5.1 Weiguang Biological Corporation Information 12.5.2 Weiguang Biological Description and Business Overview 12.5.3 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.5.5 Weiguang Biological Recent Development 12.6 Sinopharm 12.6.1 Sinopharm Corporation Information 12.6.2 Sinopharm Description and Business Overview 12.6.3 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.6.5 Sinopharm Recent Development 12.7 Shanghai RAAS 12.7.1 Shanghai RAAS Corporation Information 12.7.2 Shanghai RAAS Description and Business Overview 12.7.3 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.7.5 Shanghai RAAS Recent Development 12.8 CTBB 12.8.1 CTBB Corporation Information 12.8.2 CTBB Description and Business Overview 12.8.3 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.8.5 CTBB Recent Development 12.9 Nanyue Biopharming 12.9.1 Nanyue Biopharming Corporation Information 12.9.2 Nanyue Biopharming Description and Business Overview 12.9.3 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.9.5 Nanyue Biopharming Recent Development 12.11 Boya-Bio 12.11.1 Boya-Bio Corporation Information 12.11.2 Boya-Bio Description and Business Overview 12.11.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.11.5 Boya-Bio Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Human Immunoglobulin(pH4) for Intravenous Injection Industry Trends 13.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Drivers 13.3 Human Immunoglobulin(pH4) for Intravenous Injection Market Challenges 13.4 Human Immunoglobulin(pH4) for Intravenous Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Human Immunoglobulin(pH4) for Intravenous Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 1g/20ml Table 3. Major Manufacturers of 1.25g/25ml Table 4. Major Manufacturers of 2.5g/50ml Table 5. Major Manufacturers of 5g/100ml Table 6. Major Manufacturers of 10g/200ml Table 7. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Application (2021-2027) & (K Units) Table 8. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 9. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Regions (2016-2021) & (K Units) Table 10. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Regions (2016-2021) Table 11. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Regions (2016-2021) & (US$ Million) Table 12. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Region (2022-2027) & (K Units) Table 13. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share Forecast by Region (2022-2027) Table 14. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 15. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share Forecast by Region (2022-2027) Table 16. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Manufacturers (2016-2021) (K Units) Table 17. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Manufacturers (2016-2021) Table 18. Ranking of Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Revenue (US$ Million) in 2020 Table 19. Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Manufacturers (2016-2021) (US$ Million) Table 20. Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Manufacturers (2016-2021) Table 21. Global Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 22. Global Human Immunoglobulin(pH4) for Intravenous Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunoglobulin(pH4) for Intravenous Injection as of 2020) Table 23. Key Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection Price (2016-2021) (US$/Unit) Table 24. Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection Product Type Table 26. Date of International Manufacturers Enter into Human Immunoglobulin(pH4) for Intravenous Injection Market Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans Table 28. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021) (K Units) Table 29. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Type (2016-2021) Table 30. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2016-2021) (US$ Million) Table 31. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Type (2016-2021) Table 32. Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 33. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) & (K Units) Table 34. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share Forecast by Type (2022-2027) Table 35. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast V (2022-2027) & (US$ Million) Table 36. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share Forecast by Type (2022-2027) Table 37. Global Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 38. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 39. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Application (2016-2021) Table 40. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2016-2021) (US$ Million) Table 41. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Application (2016-2021) Table 42. Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 43. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) & (K Units) Table 44. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share Forecast by Application (2022-2027) Table 45. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 46. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share Forecast by Application (2022-2027) Table 47. Global Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 48. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units) of Key Companies (2016-2021) Table 49. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Company (2016-2021) Table 50. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue (US$ Million) by Company (2016-2021) Table 51. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Company (2016-2021) Table 52. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 53. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Type (2016-2021) Table 54. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue (US$ Million) Market Share by Type (2016-2021) Table 55. Japan Human Immunoglobulin(pH4) for Intravenous Injection Price (US$/Unit) by Type (2016-2021) Table 56. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units) by Type (2022-2027) Table 57. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Type (2022-2027) Table 58. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue (US$ Million) Market Share by Type (2022-2027) Table 59. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Type (2022-2027) Table 60. Japan Human Immunoglobulin(pH4) for Intravenous Injection Price (US$/Unit) by Type (2022-2027) Table 61. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units) by Application (2016-2021) Table 62. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Application (2016-2021) Table 63. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue (US$ Million) Market Share by Application (2016-2021) Table 64. Japan Human Immunoglobulin(pH4) for Intravenous Injection Price (US$/Unit) by Application (2016-2021) Table 65. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units) by Application (2022-2027) Table 66. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Application (2022-2027) Table 67. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue (US$ Million) Market Share by Application (2022-2027) Table 68. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Application (2022-2027) Table 69. Japan Human Immunoglobulin(pH4) for Intravenous Injection Price (US$/Unit) by Application (2022-2027) Table 70. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 71. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2021) Table 72. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million) Table 73. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2021) Table 74. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2016-2021) & (K Units) Table 75. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region (2016-2021) Table 76. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2021) & (US$ Million) Table 77. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Region (2016-2021) Table 78. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 79. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2021) Table 80. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million) Table 81. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2021) Table 82. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 83. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2021) Table 84. Latin Americaa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million) Table 85. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2021) Table 86. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 87. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2021) Table 88. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million) Table 89. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2021) Table 90. Boya-Bio Corporation Information Table 91. Boya-Bio Description and Business Overview Table 92. Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 93. Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Product Table 94. Boya-Bio Recent Development Table 95. Beijing Tiantan Biological Products Corporation Information Table 96. Beijing Tiantan Biological Products Description and Business Overview Table 97. Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 98. Beijing Tiantan Biological Products Product Table 99. Beijing Tiantan Biological Products Recent Development Table 100. Hualan Bio Corporation Information Table 101. Hualan Bio Description and Business Overview Table 102. Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 103. Hualan Bio Product Table 104. Hualan Bio Recent Development Table 105. Guangdong Shuagnlin Bio-pharmacy Corporation Information Table 106. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview Table 107. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 108. Guangdong Shuagnlin Bio-pharmacy Product Table 109. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 110. Weiguang Biological Corporation Information Table 111. Weiguang Biological Description and Business Overview Table 112. Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 113. Weiguang Biological Product Table 114. Weiguang Biological Recent Development Table 115. Sinopharm Corporation Information Table 116. Sinopharm Description and Business Overview Table 117. Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Sinopharm Product Table 119. Sinopharm Recent Development Table 120. Shanghai RAAS Corporation Information Table 121. Shanghai RAAS Description and Business Overview Table 122. Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. Shanghai RAAS Product Table 124. Shanghai RAAS Recent Development Table 125. CTBB Corporation Information Table 126. CTBB Description and Business Overview Table 127. CTBB Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. CTBB Product Table 129. CTBB Recent Development Table 130. Nanyue Biopharming Corporation Information Table 131. Nanyue Biopharming Description and Business Overview Table 132. Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. Nanyue Biopharming Product Table 134. Nanyue Biopharming Recent Development Table 135. Human Immunoglobulin(pH4) for Intravenous Injection Market Trends Table 136. Human Immunoglobulin(pH4) for Intravenous Injection Market Drivers Table 137. Human Immunoglobulin(pH4) for Intravenous Injection Market Challenges Table 138. Human Immunoglobulin(pH4) for Intravenous Injection Market Restraints Table 139. Human Immunoglobulin(pH4) for Intravenous Injection Customers List Table 140. Human Immunoglobulin(pH4) for Intravenous Injection Distributors List Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Human Immunoglobulin(pH4) for Intravenous Injection Product Picture Figure 2. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type in 2020 & 2027 Figure 3. 1g/20ml Product Picture Figure 4. 1.25g/25ml Product Picture Figure 5. 2.5g/50ml Product Picture Figure 6. 5g/100ml Product Picture Figure 7. 10g/200ml Product Picture Figure 8. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application in 2020 & 2027 Figure 9. Hospital Figure 10. Clinic Figure 11. Others Figure 12. Human Immunoglobulin(pH4) for Intravenous Injection Report Years Considered Figure 13. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size 2016-2027 (US$ Million) Figure 15. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales 2016-2027 (K Units) Figure 16. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region (2016-2021) Figure 18. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region in 2020 Figure 19. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Region (2016-2021) Figure 20. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Region in 2020 Figure 21. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Share by Manufacturer in 2020 Figure 22. The Top 10 and 5 Players Market Share by Human Immunoglobulin(pH4) for Intravenous Injection Revenue in 2020 Figure 23. Human Immunoglobulin(pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2021) Figure 25. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type in 2020 Figure 26. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Type (2016-2021) Figure 27. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Type in 2020 Figure 28. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2021) Figure 29. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application in 2020 Figure 30. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Application (2016-2021) Figure 31. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Application in 2020 Figure 32. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate 2016-2027 (K Units) Figure 33. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Share in Global Market 2016-2027 Figure 35. Japan 5 and 10 Largest Human Immunoglobulin(pH4) for Intravenous Injection Players Market Share by Revenue in Human Immunoglobulin(pH4) for Intravenous Injection in 2020 Figure 36. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Type (2016-2021) Figure 37. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate by Type in 2016 & 2020 Figure 38. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Application (2016-2021) Figure 39. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate by Application in 2016 & 2020 Figure 40. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate 2016-2021 (K Units) Figure 41. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 42. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country in 2020 Figure 43. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country in 2020 Figure 44. U.S. Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 45. U.S. Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Canada Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 47. Canada Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate 2016-2021 (K Units) Figure 49. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 50. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country in 2020 Figure 51. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country in 2020 Figure 52. Germany Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 53. Germany Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. France Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 55. France Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. U.K. Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 57. U.K. Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Italy Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 59. Italy Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Russia Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 61. Russia Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate 2016-2021 (K Units) Figure 63. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 64. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region in 2020 Figure 65. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Region in 2020 Figure 66. China Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 67. China Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 69. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. South Korea Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 71. South Korea Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. India Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 73. India Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Australia Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 75. Australia Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Taiwan Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 77. Taiwan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Indonesia Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 79. Indonesia Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Thailand Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 81. Thailand Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Malaysia Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 83. Malaysia Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Philippines Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 85. Philippines Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Vietnam Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 87. Vietnam Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate 2016-2021 (K Units) Figure 89. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 90. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country in 2020 Figure 91. Latin America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country in 2020 Figure 92. Mexico Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 93. Mexico Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Brazil Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 95. Brazil Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Argentina Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 97. Argentina Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate 2016-2021 (K Units) Figure 99. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 100. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country in 2020 Figure 101. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country in 2020 Figure 102. Turkey Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 103. Turkey Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Saudi Arabia Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 105. Saudi Arabia Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. UAE Human Immunoglobulin(pH4) for Intravenous Injection Sales Growth Rate (2016-2021) (K Units) Figure 107. UAE Human Immunoglobulin(pH4) for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 108. Human Immunoglobulin(pH4) for Intravenous Injection Value Chain Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

Boya-Bio Beijing Tiantan Biological Products Hualan Bio Guangdong Shuagnlin Bio-pharmacy Weiguang Biological Sinopharm Shanghai RAAS CTBB Nanyue Biopharming